These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20573267)

  • 1. Interventions for renal vasculitis in adults. A systematic review.
    Walters GD; Willis NS; Craig JC
    BMC Nephrol; 2010 Jun; 11():12. PubMed ID: 20573267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for renal vasculitis in adults.
    Walters GD; Willis NS; Cooper TE; Craig JC
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD003232. PubMed ID: 31927782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for renal vasculitis in adults.
    Walters G; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2015 Sep; (9):CD003232. PubMed ID: 26400765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for renal vasculitis in adults.
    Walters G; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2008 Jul; (3):CD003232. PubMed ID: 18646089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
    Hahn D; Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD005128. PubMed ID: 26258874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
    Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Wong SC; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Pravitsitthikul N; Willis NS; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2013 Oct; (10):CD002290. PubMed ID: 24166716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for lupus nephritis.
    Henderson L; Masson P; Craig JC; Flanc RS; Roberts MA; Strippoli GF; Webster AC
    Cochrane Database Syst Rev; 2012 Dec; 12():CD002922. PubMed ID: 23235592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and management of small vessel vasculitides].
    Pettersson T; Karjalainen A
    Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.
    Rhee RL; Davis JC; Ding L; Fervenza FC; Hoffman GS; Kallenberg CGM; Langford CA; McCune WJ; Monach PA; Seo P; Spiera R; St Clair EW; Specks U; Stone JH; Merkel PA
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):251-257. PubMed ID: 29371340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ANCA-associated systemic vasculitis.
    Belmont HM
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of immune suppression in systemic diseases affecting the kidney].
    Ballarín J; Díaz M
    Nefrologia; 2008; 28 Suppl 5():91-6. PubMed ID: 18847427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.